Clinical Trial Update: Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic body proton therapy for primary renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Renal Cell Carcinoma | Phase 2 | Status: RECRUITING